Menu
GWAS Study

Genome-wide association study of childhood B-cell acute lymphoblastic leukemia reveals novel African ancestry-specific susceptibility loci.

Im C, Raduski AR, Mills LJ et al.

41125582 PubMed ID
GWAS Study Type
4200 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

IC
Im C
RA
Raduski AR
ML
Mills LJ
BK
Bhattarai KR
MR
Mobley RJ
BK
Barnett KR
LZ
Lu Z
LK
Liao K
AN
Anderson N
JR
Johnson RA
LE
Langer E
HA
Hooten AJ
SA
Seif AE
BK
Bernt KM
TM
Tsang M
MB
Mamou BA
GL
Gil-de-Gómez L
WJ
Wolfson JA
FD
Friedman DN
SN
Shukla N
KL
Klesse LJ
ME
Marcotte EL
JL
Ji L
DA
Dang A
LM
Luo M
ZY
Zhong Y
LJ
Langie J
CC
Chiang CWK
DS
de Smith A
WJ
Wiemels JL
DA
DeWan A
MX
Ma X
MC
Metayer C
WZ
Wang Z
NH
Nelson HH
PN
Pankratz N
YT
Yang T
BS
Basu S
TL
Turcotte LM
YJ
Yang JJ
SD
Savic D
SM
Scheurer ME
SL
Spector LG
Chapter II

Abstract

Summary of the research findings

B-cell acute lymphoblastic leukemia (B-ALL) is the most common pediatric malignancy. Given racial/ethnic differences in incidence and outcomes, B-ALL genome-wide association studies among children of African ancestry are needed. Leveraging multi-institutional datasets with 840 African American children with B-ALL and 3360 controls, nine loci achieved genome-wide significance (P < 5 × 10-8) after meta-analysis. Two loci were established trans-ancestral susceptibility regions (IKZF1, ARID5B), while the remaining novel loci were specific to African populations. Five-year overall survival among children carrying novel risk alleles was significantly worse (83% versus 96% in non-carriers, P = 4.8 × 10-3). Novel risk variants were also associated with subtype-specific disease (P < 0.05), including higher susceptibility for a subtype overrepresented in African American children (TCF3-PBX1) and lower susceptibility for a subtype with excellent prognosis (ETV6-RUNX1). Functional experiments revealed novel B-ALL risk variants had allele-specific differences in transcriptional activity (P < 0.05) in B-cell and leukemia cell lines. These findings shed insights into ancestry-related differences in leukemogenesis and prognosis.

840 African American child cases, 3,360 African American child controls

Chapter III

Study Statistics

Key metrics and study information

4200
Total Participants
GWAS
Study Type
No
Replicated
African American or Afro-Caribbean
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.